TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Median electroencephalographic frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: melanoma-specific survival (MSS)
Endpoint domain: Mortality/survival
Primary endpoint: Incremental quality-adjusted life-years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Understanding of the menstrual cycle
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confirmation of ovulation timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 28 days mortality
Endpoint domain: Mortality/survival
Primary endpoint: length of ICU stay within 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mechanical ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adherence to isoniazid preventive therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of recurrent pneumothorax
Endpoint domain: Mortality/survival
Primary endpoint: total chest tube time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time required to remove the chest tube following air leak resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: surgical site infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: mean length of stay
Endpoint domain: Resource use
Primary endpoint: recurrence of rotator cuff tear
Endpoint domain: Adverse events/effects
Primary endpoint: Magnitude of myopia progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of statin therapy
Endpoint domain: Mortality/survival
Primary endpoint: Medication possession ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median MACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median serum C‐reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of moxifloxacin in bile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Susceptibility to smoke cigarettes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Susceptibility to smoke cigars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived friend smoking prevalence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QUALIOST total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Back pain free status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean Hb increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in SIGH-A scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CGI-S subscale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in sleep at PSQI
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Effectiveness of treatment for otitis media with effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lowest saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vision-related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Urinary dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: General health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bodily pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ulcer healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean improvement on the SNOT-20
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of antibiotic courses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean number of sinus-related physician visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High-density lipoprotein cholesterol (HDL-c) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically healed ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: tic severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Size of uterine fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: PFIT-s at awakening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative vomiting (POV) within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IL-6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reliability of penetration (SEP2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of maintenance of erection (SEP3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile function domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean plasma aldosterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Need for acetaminophen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 30-day ischemia-driven target vessel revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electrocardiographic recurrence at 1‐year follow‐up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body image improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sleep problems improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: SF-36 Mental Component Summary improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Automated measure of sedation (ARM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intrapartum MTCT
Endpoint domain: Mortality/survival
Primary endpoint: plasma levels of irisin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptom score and joint dysfunction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESR level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fracture risk
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrent symptomatic atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in croup scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death from any cause or hospitalization for cardiovascular causes
Endpoint domain: Mortality/survival
Primary endpoint: Centre of pressure excursions in the anterior-posterior direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative displacement of the centre of pressure in medial-lateral direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month progression-free survival (6-m-PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Complete clearance of acne lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent lesional clearance rate per treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absences due to infections
Endpoint domain: Adverse events/effects
Primary endpoint: percent body weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: frequency of complete root coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gain in clinical attachment level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rates at day 7
Endpoint domain: Mortality/survival
Primary endpoint: Cure rates at day 14
Endpoint domain: Mortality/survival
Primary endpoint: 1-year actuarial patient survival
Endpoint domain: Mortality/survival
Primary endpoint: 1-year actuarial graft survival
Endpoint domain: Mortality/survival
Primary endpoint: incidence of rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Dialysis independence at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mortality on dialysis
Endpoint domain: Mortality/survival
Primary endpoint: Episodes of leukopenia during CYP therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Incremental areas under the curve (IAUC) for apoB48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SF-36 mental health score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chalder fatigue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Fatigue
Primary endpoint: 10-m sprint time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Countermovement jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: perceived support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mastery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MRE 11 expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of TNF‐α concentration's decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fungal clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SIS-16 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum HDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum fibrinogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: attentional bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive core rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incremental costs per quality-adjusted life-year (QALY) gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incremental costs per vision-year gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Heart rate at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systolic blood pressure at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma ANG II concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: log PC20 histamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of perceptions about nicotine content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of perceptions about addictiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of perceptions about cancer risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WPPSI-III scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Use of age-appropriate restraints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct use of restraints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: decrease in plaque bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting epinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: resting norepinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement of early mitral flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in global strain imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median survival to rescue analgesia request
Endpoint domain: Mortality/survival
Primary endpoint: Progression to severe PPH and PRBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for invasive procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of developing caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PCO(2) gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arterial pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron deficiency anaemia treatment effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fecal calprotectin value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: cTI and CK-MB values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-month survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Time to inadequate analgesic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excessive adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: duration of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of postoperative stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Respiratory Exchange Ratio (RER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Olfactory liking for sweet foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of carbohydrate-rich bread consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of shivering after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF-I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response rate on the Barthel Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adverse drug events (ADEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Severity of illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare service costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median survival after palliative resection
Endpoint domain: Mortality/survival
Primary endpoint: lens condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal or bulbar conjunctival fluorescein staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anthropometric and body composition measurement changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical and radiographic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in basic surgical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Confidence performing knot-tying tasks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Speed of performing the simple suturing task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction in anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anemia in ZDV-exposed infants
Endpoint domain: Adverse events/effects
Primary endpoint: clinical, immunologic, or virologic disease progression in women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery of preventive services
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Disease recurrence risk
Endpoint domain: Mortality/survival
Primary endpoint: Change in LV+dP/dtmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hot flashes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global response improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in rhytides
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posttreatment erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Overall comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: End-of-day comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Conjunctival staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak pressure in the forefoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: two year primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: extremity survival
Endpoint domain: Mortality/survival
Primary endpoint: Total Constant score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnetic resonance imaging tendon score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: goblet cell density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of ARE (Adverse Respiratory Events)
Endpoint domain: Adverse events/effects
Primary endpoint: PMS symptoms as assessed by the DRSP Total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour mean arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in NYHA functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from death and major cardiac procedures
Endpoint domain: Mortality/survival
Primary endpoint: End-Diastolic Volume (EDV) measured by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Eyberg intensity scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Behavior Checklist externalizing scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compression force (N)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compression depth (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compression frequency (times/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequacy of dosage of antidepressant medication treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-rated global improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in avoidance behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: radiographic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes